BusinessAccelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018By Nasdaq OMXFeb 8, 2018, 10:25 PM UTC
BusinessMelinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the United StatesBy Nasdaq OMXJan 29, 2018, 12:00 PM UTC
BusinessMelinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial VaginosisBy Nasdaq OMXJan 18, 2018, 12:00 PM UTC
BusinessAccelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4By Nasdaq OMXJan 10, 2018, 12:57 PM UTC
BusinessMelinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease PortfolioBy Nasdaq OMXJan 8, 2018, 12:01 PM UTC
BusinessAccelerate Diagnostics to Present at the 36th Annual J.P. Morgan Healthcare Conference in San FranciscoBy Nasdaq OMXJan 4, 2018, 6:44 PM UTC
BusinessMelinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor RelationsBy Nasdaq OMXJan 2, 2018, 12:00 PM UTC
BusinessMelinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines CompanyBy Nasdaq OMXNov 29, 2017, 12:00 PM UTC
